Treatment of Pilonidal Sinus Disease Using Surgiflo as a Sealant: A New Concept

Mansoura University50 enrolled

Overview

Assessment of surgiflo injection for treating pilonidal sinus disease

Evaluation of injection of Surgiflo as a sealent in treatment of pilonidal sinus, evaluation includes recurrence, infection, complications and patient satisfaction over 2 years of follow up

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Pilonidal Sinus Disorder

Interventions

Surgiflo injectionPROCEDURE

Curettage of sinus cavity then injection of surgiflo material

Eligibility

Sex: ALLMin age: 14 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: Patients included in the study had simple midline PS with single or multiple tracts and no lateral extensions. Recurrent cases of PS after previous surgery were also included in the study Exclusion Criteria: We excluded from the study patients with severe scarring at the natal cleft due to previous surgery or infection and patients with signs of an acute abscess.

Locations (1)

Hosam Elbanna

Al Mansurah, Dakahlia Governorate, Egypt

Outcomes

Primary Outcomes

Recurrence of the condition

number of patients presenting with recurrent pilonidal sinus

Time frame: 2 years

Secondary Outcomes

Complications of the procedure

number of patients presenting with complications after injection of surgiflo

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.